- Home
- DTSS vs TRAW Comparison
DTSS vs TRAW Comparison
Compare DTSS & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- TRAW
- Stock Information
- Founded
- DTSS 2014
- TRAW 1998
- Country
- DTSS China
- TRAW United States
- Employees
- DTSS N/A
- TRAW N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- TRAW
- Sector
- DTSS Technology
- TRAW
- Exchange
- DTSS Nasdaq
- TRAW NYSE
- Market Cap
- DTSS 15.6M
- TRAW 15.0M
- IPO Year
- DTSS N/A
- TRAW 2013
- Fundamental
- Price
- DTSS $2.01
- TRAW $5.21
- Analyst Decision
- DTSS
- TRAW
- Analyst Count
- DTSS 0
- TRAW 0
- Target Price
- DTSS N/A
- TRAW N/A
- AVG Volume (30 Days)
- DTSS 76.9K
- TRAW 7.1K
- Earning Date
- DTSS 02-11-2025
- TRAW 11-14-2024
- Dividend Yield
- DTSS N/A
- TRAW N/A
- EPS Growth
- DTSS N/A
- TRAW N/A
- EPS
- DTSS N/A
- TRAW N/A
- Revenue
- DTSS $38,176,218.00
- TRAW $226,000.00
- Revenue This Year
- DTSS N/A
- TRAW $3.81
- Revenue Next Year
- DTSS N/A
- TRAW N/A
- P/E Ratio
- DTSS N/A
- TRAW N/A
- Revenue Growth
- DTSS 262.84
- TRAW N/A
- 52 Week Low
- DTSS $1.42
- TRAW $4.06
- 52 Week High
- DTSS $20.29
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- DTSS 33.61
- TRAW 54.54
- Support Level
- DTSS $1.91
- TRAW $4.62
- Resistance Level
- DTSS $2.22
- TRAW $5.19
- Average True Range (ATR)
- DTSS 0.19
- TRAW 0.31
- MACD
- DTSS -0.05
- TRAW 0.04
- Stochastic Oscillator
- DTSS 10.10
- TRAW 70.71
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.